Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice

Blood-based biomarker testing of insulin resistance (IR) and beta cell dysfunction may identify diabetes risk earlier than current glycemia-based approaches. This retrospective cohort study assessed 1,687 US patients at risk for cardiovascular disease (CVD) under routine clinical care with a compreh...

Descripción completa

Detalles Bibliográficos
Autores principales: Varvel, Stephen A., Voros, Szilard, Thiselton, Dawn L., Pottala, James V., Dall, Tara, Warnick, G. Russell, McConnell, Joseph P., Ghaedi, Leila, Sasinowski, Maciek, Graham, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137169/
https://www.ncbi.nlm.nih.gov/pubmed/25070680
http://dx.doi.org/10.1007/s12265-014-9577-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137169/
https://www.ncbi.nlm.nih.gov/pubmed/25070680
http://dx.doi.org/10.1007/s12265-014-9577-1

Ejemplares similares